Literature DB >> 11592377

Cognitive function in fibromyalgia patients.

D C Park1, J M Glass, M Minear, L J Crofford.   

Abstract

OBJECTIVE: To evaluate fibromyalgia (FM) patients for the presence of cognitive deficits and to test the hypothesis that abnormalities would fit a model of cognitive aging.
METHODS: We studied 3 groups of patients: FM patients without concomitant depression and in the absence of medications known to affect cognitive function (n = 23), age- and education-matched controls (n = 23), and education-matched older controls who were individually matched to be 20 years older (+/- 3 years) than the FM patients (n = 22). We measured speed of information processing, working memory function, free recall, recognition memory, verbal fluency, and vocabulary. We correlated performance on cognitive tasks with FM symptoms, including depression, anxiety, pain, and fatigue. We also determined if memory complaints were correlated with cognitive performance.
RESULTS: As expected, older controls performed more poorly than younger controls on speed of processing, working memory, free recall, and verbal fluency. FM patients performed more poorly than age-matched controls on all measures, with the exception of processing speed. FM patients performed much like older controls, except that they showed better speed of processing and poorer vocabulary. Impaired cognitive performance in FM patients correlated with pain complaints, but not with depressive or anxiety symptoms. FM patients reported more memory problems than did the older and younger controls, and these complaints correlated with poor cognitive performance.
CONCLUSION: Cognitive impairment in FM patients, particularly memory and vocabulary deficits, are documented in the study. Nevertheless, the intact performance on measures of information processing speed suggests that the cognitive deficits are not global. FM patients' complaints about their memory are likely to be legitimate, since their memory function is not age appropriate.

Entities:  

Mesh:

Year:  2001        PMID: 11592377     DOI: 10.1002/1529-0131(200109)44:9<2125::AID-ART365>3.0.CO;2-1

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  79 in total

1.  Executive function in chronic pain patients and healthy controls: different cortical activation during response inhibition in fibromyalgia.

Authors:  Jennifer M Glass; David A Williams; Maria-Luisa Fernandez-Sanchez; Anson Kairys; Paloma Barjola; Mary M Heitzeg; Daniel J Clauw; Tobias Schmidt-Wilcke
Journal:  J Pain       Date:  2011-09-25       Impact factor: 5.820

2.  The Relationship Between Chronic Pain and Neurocognitive Function: A Systematic Review.

Authors:  Diana M Higgins; Aaron M Martin; Dewleen G Baker; Jennifer J Vasterling; Victoria Risbrough
Journal:  Clin J Pain       Date:  2018-03       Impact factor: 3.442

Review 3.  [Cognitive impairment in patients suffering from fibromyalgia. An underestimated problem].

Authors:  T Schmidt-Wilcke; P Wood; R Lürding
Journal:  Schmerz       Date:  2010-02       Impact factor: 1.107

Review 4.  Physical inactivity and cognitive functioning: results from bed rest studies.

Authors:  Darren M Lipnicki; Hanns-Christian Gunga
Journal:  Eur J Appl Physiol       Date:  2008-09-17       Impact factor: 3.078

5.  Understanding fibromyalgia and its related disorders.

Authors: 
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2008

6.  Metabolic abnormalities in pain-processing regions of patients with fibromyalgia: a 3T MR spectroscopy study.

Authors:  P Feraco; A Bacci; Fab Pedrabissi; L Passamonti; G Zampogna; Fed Pedrabissi; N Malavolta; M Leonardi
Journal:  AJNR Am J Neuroradiol       Date:  2011-07-28       Impact factor: 3.825

Review 7.  Fibromyalgia: evolving concepts over the past 2 decades.

Authors:  Mary-Ann Fitzcharles; Peter A Ste-Marie; John X Pereira
Journal:  CMAJ       Date:  2013-05-06       Impact factor: 8.262

8.  Cognitive impairment in patients with fibromyalgia syndrome as assessed by the mini-mental state examination.

Authors:  Jose Rodríguez-Andreu; Rosario Ibáñez-Bosch; Amparo Portero-Vázquez; Xavier Masramon; Javier Rejas; Rafael Gálvez
Journal:  BMC Musculoskelet Disord       Date:  2009-12-21       Impact factor: 2.362

9.  Validation of the International Classification of Functioning, Disability and Health Core Set for chronic widespread pain from the perspective of fibromyalgia patients.

Authors:  Robin Hieblinger; Michaela Coenen; Gerold Stucki; Andreas Winkelmann; Alarcos Cieza
Journal:  Arthritis Res Ther       Date:  2009-05-14       Impact factor: 5.156

10.  Effects of naltrexone on pain sensitivity and mood in fibromyalgia: no evidence for endogenous opioid pathophysiology.

Authors:  Jarred W Younger; Alex J Zautra; Eric T Cummins
Journal:  PLoS One       Date:  2009-04-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.